Trial Profile
Safety and efficacy of endostar combined with pemetrexed plus cisplatin in Chinese treatment-naïve metastatic non-squamous non-small cell lung cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Nov 2017 New trial record
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer